Cormorant Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.23M | Sell |
|
|||||
|
2018
Q3 | $3.39M | Sell |
|
|||||
|
2018
Q2 | $5.43M | Hold |
|
|||||
|
2018
Q1 | $7.26M | Sell |
|
|||||
|
2017
Q4 | $6.56M | Hold |
|
|||||
|
2017
Q3 | $6M | Hold |
|
|||||
|
2017
Q2 | $3.52M | Sell |
|
|||||
|
2017
Q1 | $3.12M | Sell |
|
|||||
|
2016
Q4 | $1.98M | Sell |
|
|||||
|
2016
Q3 | $6.49M | Hold |
|
|||||
|
2016
Q2 | $8.12M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $2.04M | Hold |
|
|||||
|
2015
Q2 | $4M | Sell |
|
|||||
|
2015
Q1 | $6.93M | Sell |
|
|||||
|
2014
Q4 | $7.61M | Hold |
|
|||||
|
2014
Q3 | $5.39M | Hold |
|
|||||
|
2014
Q2 | $7.63M | Sell |
|
|||||
|
2014
Q1 | $10.8M | Buy |
|
|||||
|
2013
Q4 | $2.31M | Buy |
|